Jose E Krieger Selected Research

Jose E Krieger Research Topics

Disease

6	Hyperlipoproteinemia Type II (Familial Hypercholesterolemia) 01/2021 - 03/2012
6	Heart Failure 01/2020 - 05/2007
4	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 09/2009
4	Hypertension (High Blood Pressure) 10/2018 - 05/2006
4	Coronary Artery Disease (Coronary Atherosclerosis) 03/2017 - 01/2006
4	Iron Overload 01/2012 - 12/2010
3	Inflammation (Inflammations) 01/2022 - 12/2019
3	Atherosclerosis 01/2021 - 12/2019
3	Myocardial Infarction 01/2017 - 06/2009
2	Dyslipidemias (Dyslipidemia) 01/2021 - 12/2019
2	Hemochromatosis (Bronze Diabetes) 01/2012 - 04/2011
2	Hypertrophy 11/2011 - 08/2008
1	Cardiotoxicity 04/2022
1	Hypoxia (Hypoxemia) 01/2022
1	Atherosclerotic Plaque (Atheroma) 01/2022
1	Hypercholesterolemia 01/2021
1	Heart Diseases (Heart Disease) 12/2020
1	Syncope (Fainting) 11/2020
1	Cardiac Sudden Death (Sudden Cardiac Arrest) 11/2020
1	Homozygous Familial Hypercholesterolemia 10/2020
1	Chronic Kidney Failure (Chronic Renal Failure) 01/2019
1	Necrosis 01/2019
1	Sepsis (Septicemia) 01/2019
1	Endotoxemia 01/2019
1	Obesity 10/2018
1	Inborn Genetic Diseases (Disease, Hereditary) 10/2018
1	Ciliopathies 01/2018
1	Chagas Cardiomyopathy 01/2018
1	Hyperkalemia 11/2017
1	Chronic Renal Insufficiency 11/2017
1	Albuminuria 11/2017
1	Atrial Fibrillation 06/2017
1	Congenital Heart Defects (Congenital Heart Defect) 03/2017
1	Arcus Senilis 01/2017
1	Xanthomatosis (Xanthoma) 01/2017
1	Cicatrix (Scar) 08/2014
1	Type 2 Diabetes Mellitus (MODY) 10/2012
1	Stroke (Strokes) 08/2010
1	Infarction (Infarctions) 08/2010
1	Hypertriglyceridemia 09/2009

Drug/Important Bio-Agent (IBA)

4	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2019
4	oxidized low density lipoproteinIBA 01/2021 - 01/2017
4	Transferrin (beta 2 Transferrin)IBA 01/2012 - 12/2010
3	LipidsIBA 01/2022 - 01/2020
3	LDL CholesterolIBA 01/2021 - 10/2020
3	Pharmaceutical PreparationsIBA 11/2020 - 06/2017
2	Biological ProductsIBA 04/2022 - 01/2018
2	CytokinesIBA 01/2019 - 04/2009
2	Spironolactone (Aldactone)FDA LinkGeneric 01/2018 - 11/2017
2	Losartan (Cozaar)FDA LinkGeneric 11/2017 - 08/2008
2	Genetic Markers (Genetic Marker)IBA 03/2017 - 10/2012
2	Biopolymers (Biopolymer)IBA 08/2010 - 06/2009
1	tebuconazoleIBA 04/2022
1	RNA (Ribonucleic Acid)IBA 01/2022
1	Proprotein Convertase 9IBA 01/2021
1	CalciumIBA 01/2020
1	AcetoneIBA 01/2020
1	threitolIBA 01/2019
1	Inositol (Myoinositol)IBA 01/2019
1	Lactose FDA LinkGeneric 01/2019
1	Mannitol (Osmitrol)FDA LinkGeneric 01/2019
1	Tyrosine (L-Tyrosine)FDA Link 01/2019
1	Interleukin-10 (Interleukin 10)IBA 01/2019
1	Long Noncoding RNAIBA 01/2019
1	omega-Chloroacetophenone (Mace)IBA 10/2018
1	5'- O- (9- phenylxanthen- 9- yl)- 2'- deoxynebularineIBA 01/2018
1	DiureticsIBA 01/2018
1	Clonidine (ST 155)FDA LinkGeneric 01/2018
1	Mineralocorticoid Receptor AntagonistsIBA 11/2017
1	Eplerenone (Inspra)FDA LinkGeneric 11/2017
1	HomocysteineIBA 03/2017
1	Vitamin B 12 (Cyanocobalamin)FDA LinkGeneric 03/2017
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2017
1	Trimetazidine (Vastarel)IBA 08/2015
1	Troponin IIBA 08/2014
1	Connexin 43 (Connexin43)IBA 08/2014
1	EmulsionsIBA 03/2012
1	LDL Receptors (LDL Receptor)IBA 03/2012
1	ChylomicronsIBA 03/2012
1	Dietary IronIBA 01/2012
1	Ferritins (Ferritin)IBA 01/2012
1	Free RadicalsIBA 11/2011
1	Glucosephosphate Dehydrogenase (Glucose 6 Phosphate Dehydrogenase)IBA 11/2011
1	NADPH Oxidases (NAD(P)H oxidase)IBA 11/2011
1	IronIBA 04/2011
1	HepcidinsIBA 12/2010
1	CholesterolIBA 09/2009
1	Triglycerides (Triacylglycerol)IBA 09/2009
1	HDL CholesterolIBA 09/2009
1	O-(glucuronic acid 2-sulfate)-(1--3)-O-(2,5)-andydrotalitol 6-sulfateIBA 09/2009
1	Glutathione Transferase (Glutathione S-Transferase)IBA 09/2009
1	FibrinIBA 06/2009

Therapy/Procedure

3	Therapeutics 12/2020 - 01/2018
2	Mediterranean Diet 01/2021 - 12/2019
2	Transplantation 01/2017 - 08/2010
1	Intravenous Injections 01/2019
1	Ligation 01/2019
1	Punctures 01/2019
1	Drug Therapy (Chemotherapy) 01/2018
1	Cell- and Tissue-Based Therapy (Cell Therapy) 06/2009